Harbour Investments’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-26
Closed -$933 3665
2024
Q4
$933 Hold
26
﹤0.01% 3185
2024
Q3
$986 Hold
26
﹤0.01% 3095
2024
Q2
$1.18K Hold
26
﹤0.01% 2958
2024
Q1
$1.26K Hold
26
﹤0.01% 2875
2023
Q4
$1.39K Hold
26
﹤0.01% 2761
2023
Q3
$1.52K Hold
26
﹤0.01% 2613
2023
Q2
$1.64K Hold
26
﹤0.01% 2598
2023
Q1
$1.64K Hold
26
﹤0.01% 2603
2022
Q4
$1.38K Hold
26
﹤0.01% 2612
2022
Q3
$2K Hold
26
﹤0.01% 2492
2022
Q2
$2K Buy
+26
New +$1.94K ﹤0.01% 2492
2021
Q4
$3K Hold
26
﹤0.01% 2350
2021
Q3
$2K Hold
26
﹤0.01% 3375
2021
Q2
$3K Hold
26
﹤0.01% 3287
2021
Q1
$3K Buy
+26
New +$2.37K ﹤0.01% 3134

Other funds holding USNA

Harbour Investments's USNA Position: Q1 2025 in Review

Harbour Investments sold out of Usana Health Sciences (USNA) in Q1 2025, closing a stake of 26 shares — an estimated $933 sold.

Harbour Investments first reported a position in USNA in Q1 2021 and held it in 15 quarters. The position peaked at $3K in Q4 2021. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.

  • Harbour Investments reported no remaining Usana Health Sciences position as of Q1 2025 after selling out during the quarter.
  • Harbour Investments sold 26 Usana Health Sciences shares in Q1 2025, an estimated $933.
  • Harbour Investments first reported a position in Usana Health Sciences in Q1 2021 and held it in 15 quarters.
  • Harbour Investments's Usana Health Sciences position peaked at $3K in Q4 2021.
  • 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.

Based on Harbour Investments's 13F filing for Q1 2025, filed 8 May 2025.